GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ApicHope Pharmaceutical Co Ltd (SZSE:300723) » Definitions » Debt-to-Equity

ApicHope Pharmaceutical Co (SZSE:300723) Debt-to-Equity : 0.51 (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is ApicHope Pharmaceutical Co Debt-to-Equity?

ApicHope Pharmaceutical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ¥997 Mil. ApicHope Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ¥266 Mil. ApicHope Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was ¥2,474 Mil. ApicHope Pharmaceutical Co's debt to equity for the quarter that ended in Jun. 2024 was 0.51.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for ApicHope Pharmaceutical Co's Debt-to-Equity or its related term are showing as below:

SZSE:300723' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04   Med: 0.45   Max: 3.11
Current: 0.51

During the past 11 years, the highest Debt-to-Equity Ratio of ApicHope Pharmaceutical Co was 3.11. The lowest was 0.04. And the median was 0.45.

SZSE:300723's Debt-to-Equity is ranked worse than
66.15% of 839 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs SZSE:300723: 0.51

ApicHope Pharmaceutical Co Debt-to-Equity Historical Data

The historical data trend for ApicHope Pharmaceutical Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ApicHope Pharmaceutical Co Debt-to-Equity Chart

ApicHope Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.27 0.66 0.57 0.32

ApicHope Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.43 0.32 0.45 0.51

Competitive Comparison of ApicHope Pharmaceutical Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, ApicHope Pharmaceutical Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ApicHope Pharmaceutical Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ApicHope Pharmaceutical Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where ApicHope Pharmaceutical Co's Debt-to-Equity falls into.



ApicHope Pharmaceutical Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

ApicHope Pharmaceutical Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

ApicHope Pharmaceutical Co's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ApicHope Pharmaceutical Co  (SZSE:300723) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


ApicHope Pharmaceutical Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of ApicHope Pharmaceutical Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


ApicHope Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Tianhe District Zhujiang New City Jinsui Road, 17th Floor, Star International Building, Guangdong Province, Guangzhou, CHN, 510623
ApicHope Pharmaceutical Co Ltd is a fully integrated, research-oriented pharmaceutical and healthcare company. It is engaged in the research and development, production, and sale of pharmaceutical products. The company focuses on pediatric diseases, recombinant vaccines and chronic diseases.
Executives
Yang De Ming Independent director
Zhang Ming Yuan Secretary Dong
Zhang Ying Ying Supervisors
Li Han Dong Director
Ke Rui Yu Supervisors
Zhang Hui Xing Executives

ApicHope Pharmaceutical Co Headlines

No Headlines